chr15-44669058-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_StrongBP6BP7BS1
The NM_001387263.1(PATL2):āc.1146C>Gā(p.Pro382=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000229 in 1,551,320 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.0012 ( 1 hom., cov: 32)
Exomes š: 0.00012 ( 0 hom. )
Consequence
PATL2
NM_001387263.1 synonymous
NM_001387263.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.198
Genes affected
PATL2 (HGNC:33630): (PAT1 homolog 2) Predicted to enable RNA binding activity. Predicted to be involved in P-body assembly and deadenylation-dependent decapping of nuclear-transcribed mRNA. Predicted to act upstream of or within negative regulation of cytoplasmic mRNA processing body assembly. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 15-44669058-G-C is Benign according to our data. Variant chr15-44669058-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 3049657.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.198 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0012 (183/152306) while in subpopulation AFR AF= 0.00431 (179/41570). AF 95% confidence interval is 0.00379. There are 1 homozygotes in gnomad4. There are 95 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PATL2 | NM_001387263.1 | c.1146C>G | p.Pro382= | synonymous_variant | 14/18 | ENST00000682850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PATL2 | ENST00000682850.1 | c.1146C>G | p.Pro382= | synonymous_variant | 14/18 | NM_001387263.1 | A2 | ||
PATL2 | ENST00000434130.6 | c.1146C>G | p.Pro382= | synonymous_variant | 12/16 | 5 | A2 | ||
PATL2 | ENST00000560780.1 | c.579C>G | p.Pro193= | synonymous_variant | 11/15 | 2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00120 AC: 183AN: 152188Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
183
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000261 AC: 40AN: 153468Hom.: 0 AF XY: 0.000147 AC XY: 12AN XY: 81400
GnomAD3 exomes
AF:
AC:
40
AN:
153468
Hom.:
AF XY:
AC XY:
12
AN XY:
81400
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000124 AC: 173AN: 1399014Hom.: 0 Cov.: 32 AF XY: 0.0000855 AC XY: 59AN XY: 689964
GnomAD4 exome
AF:
AC:
173
AN:
1399014
Hom.:
Cov.:
32
AF XY:
AC XY:
59
AN XY:
689964
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00120 AC: 183AN: 152306Hom.: 1 Cov.: 32 AF XY: 0.00128 AC XY: 95AN XY: 74468
GnomAD4 genome
AF:
AC:
183
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
95
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PATL2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 16, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at